Literature DB >> 25347091

The sandwich technique of diaphragmatic stripping or full-thickness resection for advanced ovarian cancer: how to keep it short and simple.

Christoph Grimm1, Philipp Harter, Florian Heitz, Andreas du Bois.   

Abstract

OBJECTIVE: Residual tumor is an important prognostic factor in advanced ovarian cancer patients. A recent analysis from a large Gynecologic Oncology Group trial identified the diaphragm as the most common localization for residual tumor after surgery in advanced ovarian cancer. This stresses the need for more knowledge and training in diaphragmatic surgery in patients with advanced ovarian cancer. METHODS/MATERIALS: We aimed to describe a safe structured technique to perform transection of the peritoneal diaphragm or full-thickness resection of the diaphragm.
RESULTS: The structured technique consists of 5 steps as follows: (1) knowledge of anatomical landmarks, (2) adequate exposure of the surgical field, (3) mobilization of the liver, (4) demarcation of the resection lines of the peritoneum, and (5) mobilization of the diaphragmatic peritoneum by using the sandwich technique or performance of a full-thickness resection with subsequent suture.
CONCLUSIONS: Diaphragmatic surgery is an important part of upper abdominal surgery in advanced ovarian cancer patients. It is a safe structured procedure, which should be routinely performed to achieve optimal surgical results for these patients.

Entities:  

Mesh:

Year:  2015        PMID: 25347091     DOI: 10.1097/IGC.0000000000000309

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  2 in total

1.  Extraperitoneal Approach During Peritonectomy in the Right Upper Quadrant for Peritoneal Metastases from Ovarian Malignancies.

Authors:  Miklos Acs; Hubert Leebmann; Sebastian Häusler; Philipp Harter; Pompiliu Piso
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

2.  Application of J-Plasma in the excision of diaphragmatic lesions as part of complete cytoreduction in patients with advanced ovarian cancer.

Authors:  Vasilios Theodoulidis; Anastasia Prodromidou; Emmanouil Stamatakis; Nicholas Alexakis; Alexandros Rodolakis; Dimitrios Haidopoulos
Journal:  Mol Clin Oncol       Date:  2022-05-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.